Quick Summary:
In the global high-throughput screening (HTS) market, pharmaceutical and biotechnology companies are leveraging advancements in technology to propel drug discovery and manufacturing. HTS, with its ability to automate testing of various chemical and biological compounds, offers unprecedented opportunities to expedite these processes - a growing need in this competitive landscape. This market is projected to be fueled by acceleration of new drug developments, increased investments in disruptive technologies, and AI-driven automation.
Investing in this rapidly evolving high-throughput screening market and keeping up with its trends is necessary for decision makers, seeking to expose their organizations to a path of profound growth. This comprehensive report offers in-depth insights into key market trends, while exploring technologies such as microplate-free approach, CRISPR and RNAi, AI and machine learning, and new product and service segments. Furthermore, it offers a detailed examination of the competitive landscape, with profiles of market leaders such as Agilent Technologies, Aurora Biomed, and more. Hence this report better equips business executives to make informed decisions and build future-proof strategies.
High-throughput screening (HTS) is a drug discovery process that allows automated testing of different chemical and biological compounds for a biological target. It relies on liquid handling devices, robotics, plate readers, and dedicated software for instrumentation control and data processing. It enables sample minimization, high-speed automation, and single-molecule and low background signals detection. HTS helps scientists generate and utilize large datasets for answering complex biological questions. As a result, it finds wide applications in pharmaceuticals, biotech and academic institutes, target validation, and the identification of genes that modulate a particular biological pathway.
High-throughput Screening Market Trends:
At present, there is a rise in the utilization of HTS for minimizing the time required for manufacturing a drug. This, along with the development of new medicines for treating various life-threatening diseases, represents one of the key factors driving the market. Moreover, governments of several countries are investing in new technologies, such as a microplate-free approach, clustered regularly interspaced short palindromic repeats (CRISPR) and RNA interference (RNAi), and artificial intelligence (AI) and machine learning (ML). This, coupled with the increasing application of automation in HTS and fast data processing around the world, is propelling the growth of the market. Furthermore, key market players are introducing label-free technology to provide simple methods for studying complex biological pathways and reduce the risk of drug failure caused by toxicity. These players are also investing in research and development (R&D) activities to develop new technologies in HTS. Besides this, they are launching a time-resolved Forster resonance energy transfer (TR-FRET) version of the transcreener assay for various enzymes. These innovations are projected to bolster the growth of the market.Key Market Segmentation:
The publisher provides an analysis of the key trends in each sub-segment of the global high-throughput screening market report, along with forecasts at the global, regional and country level from 2023-2028. The report has categorized the market based on technology, products and services, applications and end user.Breakup by Technology:
- Ultra-High-Throughput Screening
- Cell-Based Assays
- Lab-on-a-Chip
- Label-Free Technology
Breakup by Products and Services:
- Instruments
- Reagents and Kits
- Services
Breakup by Applications:
- Target Identification and Validation
- Primary and Secondary Screening
- Toxicology Assessment
- Others
Breakup by End User:
- Pharmaceutical and Biotechnology Firms
- Academic and Government Institutes
- Contract Research Organizations
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Agilent Technologies Inc., Aurora Biomed Inc., Axxam S.p.A, Beckman Coulter Inc. (Danaher Corporation), Bio-RAD Laboratories Inc., Charles River Laboratories International Inc., Corning Incorporated, Luminex Corporation (DiaSorin), Perkinelmer Inc., Sygnature Discovery, Tecan Group Ltd. and Thermo Fisher Scientific.Key Questions Answered in This Report:
- How has the global high-throughput screening market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global high-throughput screening market?
- What are the key regional markets?
- What is the breakup of the market based on the technology?
- What is the breakup of the market based on the products and services?
- What is the breakup of the market based on the applications?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global high-throughput screening market and who are the key players?
- What is the degree of competition in the industry?
What is the estimated value of the Global High-throughput Screening Market?
What is the growth rate of the Global High-throughput Screening Market?
What is the forecasted size of the Global High-throughput Screening Market?
Who are the key companies in the Global High-throughput Screening Market?
Report Attribute | Details |
---|---|
No. of Pages | 139 |
Published | September 2023 |
Forecast Period | 2022 - 2028 |
Estimated Market Value ( USD | $ 23.2 Billion |
Forecasted Market Value ( USD | $ 38.3 Billion |
Compound Annual Growth Rate | 8.7% |
Regions Covered | Global |
No. of Companies Mentioned | 12 |
Table of Contents
Companies Mentioned
- Agilent Technologies Inc.
- Aurora Biomed Inc.
- Axxam S.p.A
- Beckman Coulter Inc. (Danaher Corporation)
- Bio-RAD Laboratories Inc.
- Charles River Laboratories International Inc.
- Corning Incorporated
- Luminex Corporation (DiaSorin)
- Perkinelmer Inc.
- Sygnature Discovery
- Tecan Group Ltd.
- Thermo Fisher Scientific.
Methodology
LOADING...